Lucid Diagnostics (LUCD) Earnings Analysis

Lucid Diagnostics (LUCD) next reports earnings on 2026-08-12, consensus EPS -0.04 USD. Last quarter (2026-05-14) it missed with EPS -0.07 USD vs -0.05 USD est (-40%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E -2.03.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does LUCD next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.04 USD
Revenue estimate0.00B

LUCD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.07 USD-0.05 USD-40%Miss
2026-03-25-0.1 USD-0.07 USD-42.9%Miss
2025-11-12-0.1 USD-0.06 USD-66.7%Miss
2025-08-13-0.1 USD-0.09 USD-11.1%Miss
2025-03-24-0.19 USD-0.15 USD-26.7%Miss
2024-11-13-0.2 USD-0.16 USD-25%Miss
2024-08-12-0.2 USD-0.22 USD+9.1%Beat

Beat rate: 1/7 (14%) over reported quarters with consensus data.

LUCD valuation and analyst view

Trailing P/E-2.03
Trailing EPS-0.44151 USD
Price / book24.08
Dividend yield0.00%
Market cap0.10B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target2 USD

Related research pages

Frequently asked questions

When is Lucid Diagnostics (LUCD)'s next earnings date?

Lucid Diagnostics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.04 USD and revenue estimate of 0.00B.

Did LUCD beat earnings last quarter?

In its 2026-05-14 report, LUCD posted EPS of -0.07 USD versus a -0.05 USD estimate — a miss of 40%.

What is LUCD's earnings track record?

Over the last 7 reported quarters with consensus data, LUCD beat estimates 1 times (14%).

What is LUCD's current P/E ratio and EPS?

LUCD trades at a trailing P/E of -2.03 on trailing EPS of -0.44151372772126696 USD.

What do analysts rate LUCD?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 2 USD.